1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
(
- Contribution to journal › Article
- 2005
-
Mark
Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response
(
- Contribution to journal › Article
- 1998
-
Mark
HCV-RNA levels increase during pregnancy in women with chronic hepatitis C
(
- Contribution to journal › Article
-
Mark
GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors
(
- Contribution to journal › Article
- 1997
-
Mark
Chronic non-A, non-B, non-C hepatitis: is hepatitis G/GBV-C involved?
(
- Contribution to journal › Article
-
Mark
The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C
(
- Contribution to journal › Article
- 1995
-
Mark
Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission
(
- Contribution to journal › Article
-
Mark
HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile
(
- Contribution to journal › Article
-
Mark
Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection
(
- Contribution to journal › Article
- 1993
-
Mark
Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors
(
- Contribution to journal › Article